Promega launches XpressAmp Direct Amplification reagents

The reagents are designed to allow COVID-19 testing labs to skip the RNA extraction process

picture of

Breaking News

Enesi Pharma hits milestone in thermostable solid-dose live vaccines development

Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella

NerPharMa and ICROM partner on highly potent drugs and ADC-payloads

This agreement outlines the sharing of technologies, know-how, facilities and workforce of the two companies

Evonik delivers first lipids from German facility to BioNTech

The lipids are used for Pfizer and BioNTech's COVID-19 vaccine, as part of a lipid nanoparticle

Bispecific antibodies: an exciting new class of emerging therapeutics

Since 2015, when the first bispecific received US FDA approval, these game-changing antibodies have rocketed in ...

DMC and Conagen partner to manufacture L-alanine

L-alanine is a naturally occurring amino acid used in homecare products, human nutrition, and pharmaceutical ...

CordenPharma expands lipid excipients purification

The company has been continuously investing in expanded lipid supply chain at its facilities in Switzerland, France, ...

Harnessing the power of HPAPIs: key considerations

Adam Kujath, Senior Director at Sterling Pharma Solutions, discusses the key issues that companies need to consider ...

Delegate tickets now on sale for Manufacturing Chemist Live

Taking place on 14-15 September, the event will provide a comprehensive overview on key pharmaceutical practices and ...

Recipharm and binx announce long-term supply agreement

Recipharm is a minority investor in binx health

Accelerating excipient development for inhalable dosage forms with QbD

Whether they are simply giving an oral dose the bulk it needs to permit handling and swallowing or performing more ...

API sourcing: what to look for in a supplier

Jonathan Knight, Director of Market Intelligence and New Technologies at Cambrex, presents an overview of the API ...

Bispecific antibodies in review: from cell line development to manufacturing

With the advent of a technology that targets two different epitopes simultaneously, growth in the global bispecific ...

Aker signs pharmaceutical agreement for Lysoveta therapies

Aker BioMarine will continue to seek partnerships within the pharmaceutical space to develop other therapies based on ...

Rousselot extends SiMoGel capabilities with centre-filled soft gummies

The innovative, technical features of this new dosage form invented by Rousselot will be fully detailed in R ...